History
  • No items yet
midpage
27 F. Supp. 3d 447
S.D.N.Y.
2014
Read the full case

Background

  • Multidistrict litigation alleging banks manipulated LIBOR, harming purchasers of Eurodollar futures and OTC counterparties; core complaints amended and litigated in this District.
  • Earlier rulings: LIBOR I (935 F. Supp. 2d 666) and LIBOR II (962 F. Supp. 2d 606) set pleading standards, allowed some claims to proceed, and invited renewed motions on scienter, trader-based claims, and statute-of-limitations issues.
  • Exchange-based plaintiffs sought to add day-to-day (trader-based) manipulation claims derived from Barclays and Rabobank settlements; OTC plaintiffs asserted breach of implied covenant and unjust enrichment against banks with which they contracted.
  • Court considered (a) motions to reconsider denial of trader-based allegations, (b) leave to amend to add trader-based allegations, (c) defendants’ renewed scienter challenge, (d) dismissal of CEA claims for contracts bought May 30, 2008–Apr 14, 2009 (Period 2), (e) dismissal of OTC contract/unjust enrichment claims against non-counterparty banks, and (f) dismissal of claims against Société Générale as time-barred.
  • Rulings summarized: reconsideration denied; limited leave to amend granted for trader-based claims only as to Barclays and Rabobank (Jan 2005–Aug 2007) with specific-date allegations; scienter adequately pled (conscious misbehavior/recklessness); all Period 2 CEA claims dismissed as time-barred; OTC contract and unjust enrichment claims allowed only against direct counterparties; Société Générale dismissed as untimely.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Leave to add trader-based (day-to-day) manipulation claims Plaintiffs: can now identify specific Eurodollar trades/dates tying transactions to dates when LIBOR was allegedly manipulated (from Barclays/Rabobank records) Defendants: prior pleading lacked particularity and would be futile; examples do not show impact on published LIBOR or plaintiffs’ injuries Court: Denied reconsideration; granted limited leave to amend for specific dates against Barclays and Rabobank (Jan 2005–Aug 2007) showing plausible injury and impact on published LIBOR
Scienter under the CEA Plaintiffs: pleadings show motive/opportunity and conscious misbehavior; banks knew submissions were false and knew effect on Eurodollar futures Defendants: mere market positions and knowledge insufficient; must plead intent to manipulate futures prices Court: Motive/opportunity alone insufficient, but scienter adequately pled via conscious misbehavior/recklessness (knew submissions were false, knew effect, submissions had no legitimate purpose), so motion to dismiss scienter denied
Statute of limitations for Period 2 (May 30, 2008–Apr 14, 2009) CEA claims Plaintiffs: some named funds first traded in Period 2 and lacked earlier inquiry notice; reassurances and press coverage did not put plaintiffs on inquiry notice Defendants: named plaintiffs traded in Period 1 and were on inquiry notice by May 29, 2008; Period 2 claims untimely Court: All Period 2 CEA claims time-barred; inquiry notice did not dissipate and Period 2 purchasers would have discovered probable LIBOR artificiality before Apr 15, 2009
OTC breach of implied covenant and unjust enrichment against non-counterparty banks Plaintiffs: may assert class-based or conspiracy-based theories to reach all banks; class standing can support claims against non-counterparties Defendants: contract claims require privity; unjust enrichment needs a sufficient nexus; conspiracy or class standing not a substitute for direct relationship Court: Claims dismissed as to non-counterparty banks for lack of Article III standing and insufficient nexus; claims may proceed against direct counterparties (UBS, Deutsche Bank, Barclays, Citibank, Credit Suisse)

Key Cases Cited

  • Bell Atlantic Corp. v. Twombly, 550 U.S. 544 (pleading must be plausible to survive dismissal)
  • Ashcroft v. Iqbal, 556 U.S. 662 (plausibility standard and rejection of conclusory allegations)
  • Tellabs, Inc. v. Makor Issues & Rights, Ltd., 551 U.S. 308 (standard for strong inference of scienter)
  • Foman v. Davis, 371 U.S. 178 (leave to amend under Rule 15(a) is within court's discretion)
  • Lujan v. Defenders of Wildlife, 504 U.S. 555 (Article III standing requirements)
  • American Pipe & Construction Co. v. Utah, 414 U.S. 538 (class-action tolling rule)
  • NECA-IBEW Health & Welfare Fund v. Goldman Sachs & Co., 693 F.3d 145 (distinguishing Article III, statutory, and class standing)
  • In re Amaranth Natural Gas Commodities Litig., 730 F.3d 170 (scienter and manipulation principles in commodities context)
  • In re LIBOR-Based Financial Instruments Antitrust Litigation (LIBOR I), 935 F. Supp. 2d 666 (S.D.N.Y. 2013) (prior MDL opinion setting many contested standards)
  • In re LIBOR-Based Financial Instruments Antitrust Litigation (LIBOR II), 962 F. Supp. 2d 606 (S.D.N.Y. 2013) (subsequent opinion addressing leave to amend and other issues)
Read the full case

Case Details

Case Name: In re Libor-Based Financial Instruments Antitrust Litigation
Court Name: District Court, S.D. New York
Date Published: Jun 23, 2014
Citations: 27 F. Supp. 3d 447; 2014 WL 2815645; 2014 U.S. Dist. LEXIS 86765; No. 11 MD 2262(NRB)
Docket Number: No. 11 MD 2262(NRB)
Court Abbreviation: S.D.N.Y.
Log In
    In re Libor-Based Financial Instruments Antitrust Litigation, 27 F. Supp. 3d 447